Epigenetic silencing of UBXN8 contributes to leukemogenesis in t(8;21) acute myeloid leukemia
暂无分享,去创建一个
Juan Zhang | Li Yu | Yonghui Li | E. Yang | Desheng Gong | Wei-ping Guan | Jieying Li | Synat Kang | Cai-li Han | Hong Wang | Xuefeng Gao
[1] Q. Rao,et al. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells via KLF4-mediated transactivation of P57 , 2019, Haematologica.
[2] C. Croce,et al. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC , 2018, Nature Communications.
[3] Salam A. Assi,et al. The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation , 2018, Cancer cell.
[4] Jun Yin,et al. UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells , 2018, Molecular oncology.
[5] Xiaodong Zhang,et al. Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia , 2018, Experimental & Molecular Medicine.
[6] M. Mino‐Kenudson. Immunohistochemistry for predictive biomarkers in non-small cell lung cancer. , 2017, Translational lung cancer research.
[7] J. Brodsky,et al. Guardians of the ERAD Galaxy , 2017, Cell.
[8] Michael Q. Zhang,et al. A novel epigenetic AML1‐ETO/THAP10/miR‐383 mini‐circuitry contributes to t(8;21) leukaemogenesis , 2017, EMBO molecular medicine.
[9] Li-li Wang,et al. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia , 2017, Journal of Hematology & Oncology.
[10] K. Rezvani. UBXD Proteins: A Family of Proteins with Diverse Functions in Cancer , 2016, International journal of molecular sciences.
[11] Helene Kretzmer,et al. metilene: fast and sensitive calling of differentially methylated regions from bisulfite sequencing data , 2016, Genome research.
[12] David A. Knowles,et al. Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants , 2015, Nature Communications.
[13] N. Shen,et al. AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation , 2014, Leukemia.
[14] Meng Li,et al. The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma. , 2014, Journal of hepatology.
[15] A. Abdullah,et al. Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells , 2014, Cell Death and Disease.
[16] M. Caligiuri,et al. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. , 2013, Blood.
[17] J. Brodsky,et al. The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. , 2012, Physiological reviews.
[18] R. Hartmann-Petersen,et al. The Tissue-Specific Rep8/UBXD6 Tethers p97 to the Endoplasmic Reticulum Membrane for Degradation of Misfolded Proteins , 2011, PloS one.
[19] J. Licht,et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.
[20] Wei Li,et al. BSMAP: whole genome bisulfite sequence MAPping program , 2009, BMC Bioinformatics.
[21] O. Heidenreich,et al. Transient depletion of RUNX1/RUNX1T1 by RNA interference delays tumour formation in vivo , 2009, Leukemia.
[22] S. Fang,et al. Regulation of ER-associated degradation via p97/VCP-interacting motif. , 2008, Biochemical Society transactions.
[23] F. Lo‐Coco,et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. , 2007, Cancer cell.
[24] S. Rosenberg,et al. Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes. , 2003, Cancer Research.
[25] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.